← Insider buys
NTLA

Intellia Therapeutics, Inc. · Healthcare

EVP and COO Andrew Schiermeier sold $77K of Intellia Therapeutics, Inc.

Sold$76,919
$55.86Price
1,377Shares
−8%Stake

What NTLA did after the filing

Prices for NTLA after this filing aren't in yet.

Traded Tue, Jan 5. Filed Tue, Jan 5, 3:58 PM ET, during the session. Not investment advice.